| |
|
|
Zdravilo z dovoljenjem za promet |
- |
150393 |
|
|
|
Accord Healthcare Polska Sp. z.o.o. |
|
|
|
|
Zdravilo z dovoljenjem za promet |
- |
150394 |
|
|
|
Accord Healthcare Polska Sp. z.o.o. |
|
|
|
|
Zdravilo z dovoljenjem za promet |
1.025,73€ |
150391 |
|
|
|
Accord Healthcare Polska Sp. z.o.o. |
|
|
|
|
Zdravilo z dovoljenjem za promet |
- |
150390 |
|
|
|
Accord Healthcare Polska Sp. z.o.o. |
|
|
|
|
Zdravilo z dovoljenjem za promet |
- |
150886 |
|
|
|
AOP Orphan Pharmaceuticals GmbH |
|
|
|
|
Zdravilo z dovoljenjem za promet |
- |
150885 |
|
|
|
AOP Orphan Pharmaceuticals GmbH |
|
|
|
|
Zdravilo z dovoljenjem za promet |
- |
150884 |
|
|
|
AOP Orphan Pharmaceuticals GmbH |
|
|
|
|
Zdravilo z dovoljenjem za promet |
- |
150883 |
|
|
|
AOP Orphan Pharmaceuticals GmbH |
|
|
|
|
Zdravilo z dovoljenjem za promet |
- |
043540 |
|
|
|
GlaxoSmithKline (Ireland) Limited |
|
|
C02KX02 ambrisentan |
filmsko obložena tableta |
|
|
H/Rp |
    |
P* |
1.025,73€ |
- |
- |
da |
|
|
|
|
Zdravilo z dovoljenjem za promet |
1.025,73€ |
043524 |
|
|
|
GlaxoSmithKline (Ireland) Limited |
|
|
C02KX02 ambrisentan |
filmsko obložena tableta |
|
|
H/Rp |
    |
PC* |
1.025,73€ |
- |
- |
da |
|
|